VivoSim Labs Inc. (NASDAQ: VIVS) Uses Human 3D Biology to Streamline Drug Development
Sept. 22, 2026 VivoSim Labs Inc. (NASDAQ: VIVS) is using engineered human tissues to provide pharmaceutical researchers with earlier and potentially more predictive information about experimental medicines. VivoSim’s 3D biology…
